Leukemia

KEMODOXIN

Indication : KEMODOXIN® is indicated for regression in disseminated neoplastic conditions such as acute leukemia, Wilms tumor, neuroblastoma, soft tissue and bone sarcomas, breast carcinoma, ovarian carcinoma, transitional cell bladder carcinoma, thyroid carcinoma, lung cancer, Hodgkin’s disease and non-Hodgkin’s lymphoma, bronchogenic carcinoma, and gastric carcinoma.   Compositions : Each mL contain Doxorubicin hydrochloride 2 mg […]

KEMODOXIN Read More »

KEMOTREXATE

Indication : Methotrexate is indicated in the treatment gestational chroriocarcinoma, chorio adenoma destruens and hydatidiform mole. In acute lymphatic leukemia, Methotrexate is indicated in the prophylaxis of meningeal leukemia and is used in maintenance therapy in combination with other chemotherapeutic agent, Methotrexate is also indicated in the treatment of meningeal leukemia. Methotrexate is used alone

KEMOTREXATE Read More »

DOXORUBICIN

Indication : Doxorubicin HCl is indicated for regression in disseminated neoplastic conditions such as acute leukemia, Wilms tumor, neuroblastoma, soft tissue and bone sarcomas, breast carcinoma, ovarian carcinoma, transitional cell bladder carcinoma, thyroid carcinoma, lung cancer, Hodgkin’s disease and non-Hodgkin’s lymphoma, bronchogenic carcinoma, and gastric carcinoma.   Compositions : Each mL contain Doxorubicin hydrochloride 2

DOXORUBICIN Read More »

METHOTREXATE

Indication : Methotrexate is indicated in the treatment gestational choriocarcinoma, chorio adenoma destruens and hydatidiform mole. In acute lymphatic leukemia, Methotrexate is indicated in the prophylaxis of meningeal leukemia and is used in maintenance therapy in combination with other chemotherapeutic agent, Methotrexate is also indicated in the treatment of meningeal leukemia. Methotrexate is used alone

METHOTREXATE Read More »

LEUKIVEC

Indication : Treatment of patients with a new diagnosis of Philadelphia chromosome (bcr-bl) positive (Ph+) chronic myeloid leukemia (CML) and also for the treatment of patients with Ph + CML in the chronic phase after failure of alpha interferon therapy or accelerated phase or blast cell crisis. Treatment of adult patients and children over 1

LEUKIVEC Read More »

Need More Information?

Contact CKD OTTO Pharma now for more information about our products and services.

Scroll to Top